Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor

Human tumors exhibit increased glucose uptake and metabolism as a result of high demand for ATP and anabolic substrates and this metabolotype is a negative prognostic indicator for survival. Recent studies have demonstrated that cancer cells from several tissue origins and genetic backgrounds requir...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesney, Jason, Clark, Jennifer, Lanceta, Lilibeth, Trent, John O., Telang, Sucheta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627231/
https://www.ncbi.nlm.nih.gov/pubmed/26221874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627231/
https://www.ncbi.nlm.nih.gov/pubmed/26221874

Ejemplares similares